Amarin

$7.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.18%) As of 4:13 PM UTC today

Why Robinhood?

You can buy or sell Amarin and other stocks, options, and ETFs commission-free!

About AMRN

Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland. The listed name for AMRN is Amarin Corporation plc.

CEO

John F. Thero

Employees

965

Headquarters

Dublin, Dublin

Founded

1989

Market Cap

2.81B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

7.80M

High Today

$7.80

Low Today

$7.31

Open Price

$7.75

Volume

4.97M

52 Week High

$20.41

52 Week Low

$3.36

Collections

Analyst Ratings

64%

of 11 ratings

Buy

64%

Hold

36%

Sell

AMRN Earnings

-$0.07

-$0.04

-$0.01

$0.02

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, Pre-Market